Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Pharis MohideenChief Medical Officer | DBV TechnologiesDBVT | Open-market sale | 01/29 | 02/02 | 534 sh | $4.86 | $2,595.24 | −0.4% |
DBV TechnologiesDBVT | Open-market sale | 25/12/17–25/12/18 | 25/12/19 | 3,369,093 sh3 trades | $4.60avg. | $15,484,143.17 | −31.6% | |
DBV TechnologiesDBVT | Open-market sale | 25/12/17–25/12/18 | 25/12/19 | 3,369,093 sh3 trades | $4.60avg. | $15,484,143.17 | −31.6% | |
DBV TechnologiesDBVT | Open-market sale | 25/12/17–25/12/18 | 25/12/19 | 3,369,093 sh3 trades | $4.60avg. | $15,484,143.17 | −31.6% | |
DBV TechnologiesDBVT | Open-market sale | 25/12/17–25/12/18 | 25/12/19 | 3,369,093 sh3 trades | $4.60avg. | $15,484,143.17 | −31.6% | |
DBV TechnologiesDBVT | Open-market sale | 25/12/17–25/12/18 | 25/12/19 | 3,369,093 sh3 trades | $4.60avg. | $15,484,143.17 | −31.6% | |
DBV TechnologiesDBVT | Open-market sale | 25/11/20–25/11/21 | 25/11/25 | 8,120 sh2 trades | $2.86avg. | $23,206.96 | −7.4% | |
Pharis MohideenChief Medical Officer | DBV TechnologiesDBVT | Open-market sale | 25/07/29 | 25/07/31 | 464 sh | $2.22 | $1,030.08 | −0.4% |
Pharis MohideenChief Medical Officer | DBV TechnologiesDBVT | Open-market sale | 25/05/22 | 25/05/27 | 397 sh | $1.84 | $730.48 | −0.4% |
Pharis MohideenChief Medical Officer | DBV TechnologiesDBVT | Open-market sale | 25/01/30 | 25/01/31 | 600 sh | $0.85 | $510 | −0.5% |
DBV TechnologiesDBVT | Open-market sale | 24/11/22–24/11/25 | 24/11/27 | 907 sh2 trades | $0.55avg. | $503.31 | −0.8% | |
Pharis MohideenChief Medical Officer | DBV TechnologiesDBVT | Open-market sale | 24/11/21 | 24/11/25 | 2,350 sh | $0.54 | $1,269 | −2.1% |
Pharis MohideenChief Medical Officer | DBV TechnologiesDBVT | Open-market sale | 24/07/29 | 24/07/31 | 1,785 sh | $0.98 | $1,749.3 | −2.2% |
DBV TechnologiesDBVT | Open-market sale | 24/05/22–24/05/24 | 24/05/29 | 1,042 sh2 trades | $1.37avg. | $1,424.76 | −1.3% | |
Daniel TasseCEO | DBV TechnologiesDBVT | Open-market buy | 24/03/08 | 24/03/11 | 17,094 sh | $0.83 | $14,188.02 | No record |
Adora NduDirector | DBV TechnologiesDBVT | Open-market buy | 24/02/06 | 24/02/08 | 1,825 sh | $0.89 | $1,624.25 | No record |
Pharis MohideenChief Medical Officer | DBV TechnologiesDBVT | Open-market sale | 23/11/22 | 23/12/19 | 2,245 sh | $1.74 | $3,906.3 | −2.7% |
Timothy E. MorrisDirector | DBV TechnologiesDBVT | Open-market buy | 23/08/25 | 23/08/28 | 12,000 sh | $1.52 | $18,240 | No record |
DBV TechnologiesDBVT | Open-market sale | 22/11/24–23/05/24 | 23/08/14 | 2,261 sh2 trades | $3.02avg. | $6,821.22 | −4.4% | |
Daniel B. SolandDirector | DBV TechnologiesDBVT | Open-market buy | 23/08/01 | 23/08/03 | 15,000 sh | $1.62 | $24,300 | +300.0% |